mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.003 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.006 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.006 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.007 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.008 |